Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Kitov Pharmaceuticals Holdings Net Profit Margin 2014-2019 | KTOV

Kitov Pharmaceuticals Holdings net profit margin from 2014 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
  
Kitov Pharmaceuticals Holdings Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.014B $0.001B
Kitov Pharmaceuticals Holdings Ltd. is a pharmaceutical company which focused on the development of therapeutic candidates. The company's product candidate consists of KIT-302, is formulated for treatment of pain caused by osteoarthritis and hypertension, which can be pre-existing or caused by the treatment for OA. Kitov Pharmaceuticals Holdings Ltd. is based in Jerusalem, Israel.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.714B 10.07
Zoetis (ZTS) United States $57.208B 34.22
Astellas Pharma (ALPMY) Japan $32.299B 16.13
Eisai (ESALY) Japan $21.618B 41.69
UCB SA (UCBJF) Belgium $15.697B 0.00
Grifols, S.A (GRFS) Spain $15.387B 20.16
Merck (MKGAF) Germany $14.824B 20.23
Neurocrine Biosciences (NBIX) United States $10.727B 506.43
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $9.077B 18.39
IPSEN SA ADR (IPSEY) France $9.039B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.378B 10.70
Catalent (CTLT) United States $7.550B 30.71
Arrowhead Pharmaceuticals (ARWR) United States $6.272B 94.97
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.851B 17.44
FibroGen (FGEN) United States $4.113B 120.87
United Therapeutics (UTHR) United States $3.959B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.618B 13.22
Nektar Therapeutics (NKTR) United States $3.494B 0.00
Evotec AG (EVTCY) Germany $3.326B 54.42
Sage Therapeutics (SAGE) United States $3.118B 0.00
PTC Therapeutics (PTCT) United States $3.046B 0.00
Heron Therapeutics (HRTX) United States $2.309B 0.00
Xencor (XNCR) United States $2.303B 70.02
Portola Pharmaceuticals (PTLA) United States $2.206B 0.00
Zogenix (ZGNX) United States $2.017B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.934B 61.65
Pacira Pharmaceuticals (PCRX) United States $1.892B 55.99
Tilray (TLRY) Canada $1.848B 0.00
ChemoCentryx (CCXI) United States $1.802B 0.00
USANA Health Sciences (USNA) United States $1.612B 17.20
Corcept Therapeutics (CORT) United States $1.497B 18.19
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.414B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.242B 28.37
Theravance Biopharma (TBPH) Cayman Islands $1.191B 0.00
ArQule (ARQL) United States $1.148B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.110B 7.57
Karyopharm Therapeutics (KPTI) United States $1.096B 0.00
Endo (ENDP) Ireland $1.093B 2.01
Spectrum Pharmaceuticals (SPPI) United States $1.073B 0.00
Radius Health (RDUS) United States $1.001B 0.00
Aerie Pharmaceuticals (AERI) United States $0.896B 0.00
Flexion Therapeutics (FLXN) United States $0.725B 0.00
Akebia Therapeutics (AKBA) United States $0.721B 0.00
Collegium Pharmaceutical (COLL) United States $0.680B 0.00
TherapeuticsMD (TXMD) United States $0.648B 0.00
Translate Bio (TBIO) United States $0.583B 0.00
ImmunoGen (IMGN) United States $0.582B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.485B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.485B 58.88
Concordia (CXRXF) Canada $0.473B 0.00
Organogenesis Holdings (ORGO) United States $0.456B 0.00
Harpoon Therapeutics (HARP) United States $0.442B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Molecular Templates (MTEM) United States $0.438B 0.00
Dermira (DERM) United States $0.430B 0.00
Ardelyx (ARDX) United States $0.428B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.403B 17.38
Indivior (INVVY) United States $0.390B 1.41
BioCryst Pharmaceuticals (BCRX) United States $0.386B 0.00
DURECT (DRRX) United States $0.383B 0.00
Recro Pharma (REPH) United States $0.369B 0.00
Siga Technologies (SIGA) United States $0.368B 8.41
Innate Pharma SA (IPHYF) France $0.358B 0.00
Lannett Co Inc (LCI) United States $0.342B 3.99
OptiNose (OPTN) United States $0.342B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.320B 0.00
Rafael Holdings (RFL) United States $0.291B 0.00
GlycoMimetics (GLYC) United States $0.255B 0.00
Jounce Therapeutics (JNCE) United States $0.253B 3.38
Matinas Biopharma Holdings (MTNB) United States $0.252B 0.00
KalVista Pharmaceuticals (KALV) United States $0.252B 0.00
Calithera Biosciences (CALA) United States $0.238B 0.00
Xeris Pharmaceuticals (XERS) United States $0.234B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.216B 0.00
Aquestive Therapeutics (AQST) United States $0.209B 0.00
Ocular Therapeutix (OCUL) United States $0.201B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 32.60
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Concert Pharmaceuticals (CNCE) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.146B 0.00
IMV INC (IMV) Canada $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.143B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.143B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.139B 0.00
CannTrust Holdings (CTST) Canada $0.112B 0.00
Cardiome Pharma (CORV) Canada $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
CV Sciences (CVSI) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.085B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.45
Otonomy (OTIC) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
MediWound (MDWD) Israel $0.074B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
PolarityTE (PTE) United States $0.070B 0.00
Capnia (SLNO) United States $0.069B 0.00
Aclaris Therapeutics (ACRS) United States $0.067B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Natural Alternatives (NAII) United States $0.057B 14.27
SCYNEXIS (SCYX) United States $0.057B 0.00
Novan (NOVN) United States $0.057B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.057B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Nivalis Therapeutics (ALPN) United States $0.055B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
AgeX Therapeutics (AGE) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
Mast Therapeutics (SVRA) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
IsoRay (ISR) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
Biomerica (BMRA) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
Shineco (TYHT) China $0.022B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Vical (BBI) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00